-
31.发明公开
公开(公告)号：KR1020170014562A
公开(公告)日：2017-02-08
申请号：KR1020150108154
申请日：2015-07-30
Applicant: 한국과학기술연구원 , 사회복지법인 삼성생명공익재단
IPC: G01N33/574 , G01N27/62
Abstract: 일양상에따른 PF4 측정제제를포함하는대장암진단용조성물, 키트, 및이를이용한대장암진단방법을제공한다. 이에따르면, 대장암을간편하게진단할수 있고, 대장암을높은정확도및 특이도로진단하는데이용할수 있다.
-
公开(公告)号：KR1020150120132A
公开(公告)日：2015-10-27
申请号：KR1020140045961
申请日：2014-04-17
Applicant: 한국과학기술연구원
IPC: H01M4/13 , H01M4/134 , H01M4/133 , H01M4/139 , H01M4/1395 , H01M4/38 , H01M4/587 , H01M10/052
CPC classification number: H01M4/13 , H01M4/133 , H01M4/134 , H01M4/139 , H01M4/1395 , H01M4/38 , H01M4/386 , H01M4/587 , H01M10/052
Abstract: 본발명은리튬이차전지용음극에관한것으로서집전체, 상기집전체상에형성된탄소재코팅층, 및상기탄소재코팅층상에정렬된금속촉매에의해유도성장된실리콘나노와이어층을특징으로하며, 탄소재코팅층과실리콘나노와이어층의도입과같은구조개선을통해, 초기비용량이실리콘계음극활물질의이론적용량과유사한수치를나타냈으며, 쿨롱효율도거의 100%에이르는뛰어한전지성능을가질뿐만아니라사이클특성도우수하다.
Abstract translation: 锂二次电池用负极技术领域本发明涉及锂二次电池用负极，其包括：集电体; 形成在集电体上的碳材料被覆层; 以及硅纳米线层，其在碳材料涂层上排列并被金属催化剂诱导和生长。 作为碳材料被覆层和硅纳米线层的导入等结构的改进，初始比容量与硅系负极活性物质的理论容量相同， 库仑效率近100％; 电池的性能可以很好; 并且电池的循环性能可以很好。
-
公开(公告)号：KR1020150118304A
公开(公告)日：2015-10-22
申请号：KR1020140043949
申请日：2014-04-14
Applicant: 한국과학기술연구원
IPC: H01M4/38 , H01M4/583 , H01M4/1395 , H01M4/1393 , H01M4/134 , H01M10/052
CPC classification number: H01M4/133 , H01M4/0426 , H01M4/0428 , H01M4/134 , H01M4/1393 , H01M4/1395 , H01M4/386 , H01M10/0525 , Y02E60/122
Abstract: 본발명은다공성실리콘층을포함하는리튬이차전지용음극, 이의제조방법및 이를포함하는리튬이차전지에관한것으로, 본발명에따르면, 다공성실리콘층; 상기다공성실리콘층과접전체사이에탄소층을포함하는구조로개선함으로써, 충/방전시에발생하는부피변화를효과적으로제어하고, 집전체와우수한전도성및 밀착력을가지는리튬이차전지용음극은용량및 사이클특성이향상되며, 이를이용한리튬이차전지는고출력, 고용량, 장수명의특징을갖는다.
Abstract translation: 本发明涉及包括多孔硅层的锂二次电池用负极及其制造方法以及包含该多孔硅层的锂二次电池。 负极通过包括：多孔硅层改善结构， 以及多孔硅层和集电体之间的碳层，从而有效地控制在充放电期间产生的体积变化，具有优异的导电性和与集电器的粘附性，以具有增强的容量和循环特性，并且使用 同样具有产量高，容量大，寿命长的特点。
-
公开(公告)号：KR1020150112338A
公开(公告)日：2015-10-07
申请号：KR1020140036274
申请日：2014-03-27
Applicant: 한국과학기술연구원
IPC: H01M4/525 , H01M4/505 , H01M4/485 , H01M4/139 , H01M10/052
CPC classification number: Y02E60/122 , Y02T10/7011 , H01M4/525 , H01M4/139 , H01M4/485 , H01M4/505 , H01M4/52 , H01M10/052
Abstract: 본발명은코어-쉘구조의양극활물질및 이의제조방법에관한것으로리튬산화물을포함하는코어부및 상기코어부의표면에전이금속산화물을코팅한후 열처리하여형성된알파(alpha)상의쉘부를포함함으로써, 리튬이차전지의고용량및 고출력을부여하고사이클특성및 에너지밀도를향상시킬수 있다.
Abstract translation: 本发明涉及具有核 - 壳结构的正极活性物质及其制造方法。 本发明可以包括：含有氧化锂的核心单元; 以及通过在核心单元的表面上涂覆过渡金属氧化物并热处理结果而形成的α相壳单元。 因此，本发明可以给锂二次电池提供高容量和高功率，并提高速率性能和能量密度。
-
公开(公告)号：KR1020120096842A
公开(公告)日：2012-08-31
申请号：KR1020110016203
申请日：2011-02-23
Applicant: 한국과학기술연구원
Inventor： 추현아 , 배애님 , 조용서 , 이효선 , 이지은 , 조경희 , 임혜원 , 서선희 , 송치만 , 정혜진 , 남길수 , 금교창 , 김동진 , 최경일 , 최기현 , 이재균 , 강용구 , 박웅서 , 이주현 , 신선미 , 아미드,압둘와히드 , 김영수 , 민선준
IPC: C07D413/12 , A61K31/496 , A61P25/00 , A61P9/00
CPC classification number: C07D413/12
Abstract: PURPOSE: A 5-(substituted alkylaminomethyl)isoxazole based compound as T-type calcium channel blocker is provided to have excellent activity as an antagonist of T- type calcium ion channel. CONSTITUTION: A 5-(substituted alkylaminomethyl)isoxazole based compound as T-type calcium channel blocker is represented by chemical formula 1. The encephalopathy therapy and for prevention agent selected from epilepsy, depression, Parkinson's disease, dementia, sleep disorder, an agent for cancer treatment and prevention, an agent for heart disease treatment and prevention selected from hypertensive, cardiac arrhythmia, angina, myocardial infarction, congestive heart failure, pharmaceutical composition for alleviating pain selected from neuropathic pain and chronic and acute pain includes a compound represented by chemical formula 1.
Abstract translation: 目的：提供作为T型钙通道阻滞剂的5-（取代的烷基氨基甲基）异恶唑基化合物作为T-型钙离子通道的拮抗剂具有优异的活性。 构成：以化学式1表示作为T型钙通道阻断剂的5-（取代烷基氨基甲基）异恶唑类化合物。脑病治疗和预防药物选自癫痫，抑郁症，帕金森病，痴呆，睡眠障碍， 癌症治疗和预防，选自高血压，心律失常，心绞痛，心肌梗塞，充血性心力衰竭，减轻选自神经性疼痛和慢性和急性疼痛的疼痛的药物组合物的心脏病治疗和预防剂，包括由化学式 1。
-
Patent Agency Ranking
公开(公告)号：KR1020110020023A
公开(公告)日：2011-03-02
申请号：KR1020090077687
申请日：2009-08-21
Applicant: 한국과학기술연구원
IPC: C07D413/12 , C07D413/10
Abstract: PURPOSE: An oxazole-piperazine compound having a pharmaceutical activity with respect to T-type calcium channel is provided to ensure excellent activity as an antagonist of the channel and to prevent and treat cancer, epilepsy, heart diseases, and pain. CONSTITUTION: An oxazole-piperazine compounds is denoted by chemical formula 1. A pharmaceutical composition for treating epilepsy, cancer, hypertension, myocardial infarction, neuropathic pain, and acute and chronic pain contains the oxazole-piperazine compound of chemical formula 1. The compound of chemical formula 1 is prepared by reacting piperazine-amine compound of chemical formula 2 and oxazole aldehyde compound of chemical formula 3 by reductive amination. The reductive amination is performed under the presence of molecules of 4-8 meshes and NaBH(OAc)_3, NaBH_3CN, or NaBH_4.
Abstract translation: 目的：提供相对于T型钙通道具有药学活性的恶唑 - 哌嗪化合物，以确保作为通道拮抗剂的优异活性，并预防和治疗癌症，癫痫，心脏病和疼痛。 构成：化学式1表示恶唑 - 哌嗪化合物。用于治疗癫痫，癌症，高血压，心肌梗死，神经性疼痛和急性和慢性疼痛的药物组合物含有化学式1的恶唑 - 哌嗪化合物。 化学式1通过化学式2的哌嗪 - 胺化合物和化学式3的恶唑醛化合物通过还原胺化反应来制备。 还原胺化在4-8目和NaBH（OAc）3，NaBH 3 CN或NaBH 4的分子存在下进行。
-
公开(公告)号：KR100343947B1
公开(公告)日：2002-07-22
申请号：KR1019990041613
申请日：1999-09-28
Applicant: 한국과학기술연구원
IPC: C07D413/06
Abstract: 본발명은화학식 1을갖는이소옥사졸피페라진계열의화합물또는그 염의제조방법및 상기방법에의해만들어진라이브러리에관한것으로, 상기방법은화학식 2의화합물과화학식 3의화합물을염기및 염소화제의존재하에 1,3-쌍극자고리화첨가반응시켜화학식 1 또는그 염의화합물을제조하는것으로구성된다. 그화학식 1, 2, 3과반응식 1은다음과같다. 상기화학식 1, 2, 3과반응식 1에서, R및 R는페닐, 벤질, 할로겐화페닐, C-C의알킬기로치환된페닐, C-C의알콕시기로치환된페닐, (트리플루오로)메틸페닐, 피리딜등의페닐유도체를말하며, R-R는수소이며, X는질소이며,는이중결합또는삼중결합을의미하며,는이중결합또는단일결합을의미한다.
-
-
-
-
-
-
-
Search Results
61
records
(took 0.027 seconds)
